COO
COOPER COMPANIES, INC.
Company overview
- Market capitalization
- $10.76B
- Employees
- 15,000
- Latest publication
- 2026-09-29
About COOPER COMPANIES, INC.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Financial statements
Income Quarterly
| Metric | Q3 20262026-07-31 · USD | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD | Q3 20242024-07-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Other (income) expense, net | -1,300,000USD | — | — | — | — | — | — | — |
| Comprehensive income | 412,800,000USD | — | — | — | — | — | — | — |
| Net sales | 1,066,200,000USD | — | — | — | — | — | — | — |
| Cash flow hedges | -1,500,000USD | — | — | — | — | — | — | — |
| Cost of sales | 354,300,000USD | — | — | — | — | — | — | — |
| Basic | 193USD/share | — | — | — | — | — | — | — |
| Net income | 432,800,000USD | — | — | — | — | — | — | — |
| Provision for income taxes (Note 5) | -231,000,000USD | — | — | — | — | — | — | — |
| Diluted | 2.24USD/share | — | — | — | — | — | — | — |
| Operating income | 222,000,000USD | — | — | — | — | — | — | — |
| Selling, general and administrative expense | 401,300,000USD | — | — | — | — | — | — | — |
| Foreign currency translation adjustment | -18,500,000USD | — | — | — | — | — | — | — |
| Amortization of intangibles | 47,000,000USD | — | — | — | — | — | — | — |
| Income before income taxes | 201,800,000USD | — | — | — | — | — | — | — |
| Interest expense | 21,500,000USD | — | — | — | — | — | — | — |
| Gross profit | 711,900,000USD | — | — | — | — | — | — | — |
| Research and development expense | 41,600,000USD | — | — | — | — | — | — | — |
| Total Revenue | — | 1,024,099,999USD | 1,065,200,000USD | 1,060,300,000USD | 1,002,300,000USD | 964,700,000USD | 1,018,400,000USD | 1,002,800,000USD |
| Cost Of Revenue | — | 328,899,999USD | 464,200,000USD | 368,300,000USD | 323,200,000USD | 304,500,000USD | 340,700,000USD | 339,800,000USD |
| Gross Profit | — | 695,200,000USD | 601,000,000USD | 692,000,000USD | 679,100,000USD | 660,200,000USD | 677,700,000USD | 663,000,000USD |
| Research Development | — | 44,300,000USD | 41,400,000USD | 44,600,000USD | 45,500,000USD | 40,700,000USD | 37,700,000USD | 39,000,000USD |
| Selling General Administrative | — | 390,200,000USD | 419,200,000USD | 421,700,000USD | 399,000,000USD | 387,900,000USD | 391,400,000USD | 381,100,000USD |
| Unclassified Operating Expenses | — | 47,900,000USD | — | 50,000,000USD | 49,800,000USD | 49,600,000USD | 50,200,000USD | 50,400,000USD |
| Total Operating Expenses | — | 482,400,000USD | 460,600,000USD | 516,300,000USD | 494,300,000USD | 478,200,000USD | 479,300,000USD | 470,500,000USD |
| Operating Income | — | 212,800,000USD | 140,400,000USD | 175,700,000USD | 184,800,000USD | 182,000,000USD | 198,400,000USD | 192,500,000USD |
| Interest Expense | — | 22,400,000USD | 24,400,000USD | 25,400,000USD | 33,300,000USD | 26,000,000USD | 27,000,000USD | 28,500,000USD |
| Net Interest Income | — | -22,400,000USD | -24,400,000USD | -25,400,000USD | -24,200,000USD | -26,000,000USD | -27,000,000USD | -28,500,000USD |
| Income Before Tax | — | 192,200,000USD | 116,800,000USD | 151,900,000USD | 144,500,000USD | 153,300,000USD | 168,600,000USD | 163,700,000USD |
| Income Tax Expense | — | 61,400,000USD | 32,200,000USD | 53,600,000USD | 56,800,000USD | 49,000,000USD | 51,100,000USD | 59,000,000USD |
| Tax Provision | — | 61,400,000USD | 32,200,000USD | 53,600,000USD | 56,800,000USD | 49,000,000USD | 51,100,000USD | 59,000,000USD |
| Net Income | — | 130,800,000USD | 84,600,000USD | 98,300,000USD | 87,700,000USD | 104,300,000USD | 117,500,000USD | 104,700,000USD |
| Net Income From Continuing Ops | — | 130,800,000USD | 84,600,000USD | 98,300,000USD | 87,700,000USD | 104,300,000USD | 117,500,000USD | 104,700,000USD |
| Ebit | — | 214,600,000USD | 116,800,000USD | 177,300,000USD | 168,700,000USD | 179,300,000USD | 195,600,000USD | 192,200,000USD |
| Ebitda | — | 310,100,000USD | 215,200,000USD | 272,700,000USD | 261,300,000USD | 270,300,000USD | 286,600,000USD | 281,200,000USD |
| Depreciation And Amortization | — | 95,500,000USD | 98,400,000USD | 95,400,000USD | 92,600,000USD | 91,000,000USD | 91,000,000USD | 89,000,000USD |
| Reconciled Depreciation | — | 95,500,000USD | 98,400,000USD | 95,400,000USD | 92,600,000USD | 91,000,000USD | 91,000,000USD | 89,000,000USD |
| Total Other Income Expense Net | — | -20,600,000USD | -23,600,000USD | -23,800,000USD | -40,300,000USD | -28,700,000USD | -29,800,000USD | -28,800,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD | FY 20192019-10-31 · USD | FY 20182018-10-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,092,400,000USD | 3,895,400,000USD | 3,593,200,000USD | 3,308,400,000USD | 2,922,500,000USD | 2,430,900,000USD | 2,653,400,000USD | 2,532,800,000USD |
| Cost Of Revenue | 1,609,500,000USD | 1,299,700,000USD | 1,235,300,000USD | 1,168,800,000USD | 966,700,000USD | 896,100,000USD | 896,600,000USD | 900,500,000USD |
| Gross Profit | 2,482,900,000USD | 2,595,700,000USD | 2,357,900,000USD | 2,139,600,000USD | 1,955,800,000USD | 1,534,800,000USD | 1,756,800,000USD | 1,632,300,000USD |
| Research Development | 172,200,000USD | 155,100,000USD | 137,400,000USD | 110,300,000USD | 92,700,000USD | 93,300,000USD | 86,700,000USD | 84,800,000USD |
| Selling General Administrative | 1,627,800,000USD | 1,533,700,000USD | 1,501,200,000USD | 1,342,200,000USD | 1,211,200,000USD | 992,500,000USD | 996,200,000USD | 973,300,000USD |
| Total Operating Expenses | 1,800,000,000USD | 1,890,000,000USD | 1,824,800,000USD | 1,632,000,000USD | 1,450,000,000USD | 1,223,000,000USD | 1,228,700,000USD | 1,204,800,000USD |
| Operating Income | 682,900,000USD | 705,700,000USD | 533,100,000USD | 507,600,000USD | 505,800,000USD | 311,800,000USD | 546,700,000USD | 403,100,000USD |
| Interest Expense | 100,000,000USD | 114,300,000USD | 105,300,000USD | 57,300,000USD | 23,100,000USD | 36,800,000USD | 68,000,000USD | 82,700,000USD |
| Net Interest Income | -100,000,000USD | -114,300,000USD | -105,300,000USD | -57,300,000USD | -23,100,000USD | -36,800,000USD | -68,000,000USD | -82,700,000USD |
| Income Before Tax | 566,500,000USD | 582,300,000USD | 412,900,000USD | 475,300,000USD | 491,500,000USD | 266,500,000USD | 477,400,000USD | 331,900,000USD |
| Income Tax Expense | 191,600,000USD | 190,000,000USD | 118,700,000USD | 89,500,000USD | -2,453,200,000USD | 28,100,000USD | 10,700,000USD | 192,000,000USD |
| Tax Provision | 191,600,000USD | 190,000,000USD | 118,700,000USD | 89,500,000USD | -2,453,200,000USD | 28,100,000USD | 10,700,000USD | 192,000,000USD |
| Net Income | 374,900,000USD | 392,300,000USD | 294,200,000USD | 385,800,000USD | 2,944,700,000USD | 238,400,000USD | 466,700,000USD | 139,900,000USD |
| Net Income From Continuing Ops | 374,900,000USD | 392,300,000USD | 294,200,000USD | 385,800,000USD | 2,944,700,000USD | 238,400,000USD | 466,700,000USD | 139,900,000USD |
| Ebit | 630,400,000USD | 696,600,000USD | 518,200,000USD | 532,600,000USD | 514,600,000USD | 303,300,000USD | 545,400,000USD | 414,600,000USD |
| Ebitda | 1,053,400,000USD | 1,071,700,000USD | 885,900,000USD | 878,700,000USD | 823,900,000USD | 590,400,000USD | 826,200,000USD | 689,700,000USD |
| Depreciation And Amortization | 423,000,000USD | 375,100,000USD | 367,700,000USD | 346,100,000USD | 309,300,000USD | 287,100,000USD | 280,800,000USD | 275,100,000USD |
| Reconciled Depreciation | 377,400,000USD | 375,100,000USD | 186,200,000USD | 179,500,000USD | 146,100,000USD | 287,100,000USD | 280,800,000USD | 275,100,000USD |
| Total Other Income Expense Net | -116,400,000USD | -123,400,000USD | -120,200,000USD | -32,300,000USD | -14,300,000USD | -45,300,000USD | -91,400,000USD | -71,200,000USD |
| Unclassified Operating Expenses | — | 201,200,000USD | 186,200,000USD | 179,500,000USD | 146,100,000USD | 137,200,000USD | 145,400,000USD | 146,700,000USD |
| Net Income Applicable To Common Shares | — | — | 294,200,000USD | 385,800,000USD | 2,944,700,000USD | 238,400,000USD | 466,700,000USD | 139,900,000USD |
| Interest Income | — | — | — | 57,300,000USD | 23,100,000USD | 36,800,000USD | 70,200,000USD | 86,100,000USD |
| Non Operating Income Net Other | — | — | — | 25,000,000USD | 8,800,000USD | -8,500,000USD | -1,300,000USD | 11,500,000USD |
| Minority Interest | — | — | — | — | — | 200,000USD | 200,000USD | 200,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 400,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-07-31 · USD | Q2 20262026-04-30 · USD | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Noncontrolling interests | 200,000USD | — | — | — | — | — | — | — |
| Other intangibles, net (Note 3) | 1,445,900,000USD | — | — | — | — | — | — | — |
| Total current liabilities | 1,866,600,000USD | — | — | — | — | — | — | — |
| Deferred tax liabilities | 94,200,000USD | — | — | — | — | — | — | — |
| Inventories (Note 2) | 911,500,000USD | — | — | — | — | — | — | — |
| Short term debt (Note 4) | 628,100,000USD | — | — | — | — | — | — | — |
| Accrued litigation liability (Note 9) | 316,500,000USD | — | — | — | — | — | — | — |
| Other assets | 656,900,000USD | — | — | — | — | — | — | — |
| Employee compensation and benefits | 174,600,000USD | — | — | — | — | — | — | — |
| Total liabilities | 4,345,000,000USD | — | — | — | — | — | — | — |
| Long term debt (Note 4) | 1,916,100,000USD | — | — | — | — | — | — | — |
| Deferred tax assets | 2,267,900,000USD | — | — | — | — | — | — | — |
| Deferred revenue | 208,700,000USD | — | — | — | — | — | — | — |
| Accounts payable | 251,200,000USD | — | — | — | — | — | — | — |
| Deferred revenue (Note 2) | 129,600,000USD | — | — | — | — | — | — | — |
| Retained earnings | 8,129,000,000USD | — | — | — | — | — | — | — |
| Trade accounts receivable, net of allowance for credit losses of $76.1 at July 31, 2026, and $51.9 at October 31, 2025 | 788,900,000USD | — | — | — | — | — | — | — |
| Total Cooper stockholders’ equity | 8,328,200,000USD | — | — | — | — | — | — | — |
| Property, plant and equipment, net | 2,144,900,000USD | — | — | — | — | — | — | — |
| Total liabilities and stockholders’ equity | 12,673,400,000USD | — | — | — | — | — | — | — |
| Total assets | 12,673,400,000USD | — | — | — | — | — | — | — |
| Other current liabilities | 366,600,000USD | — | — | — | — | — | — | — |
| Accumulated other comprehensive loss | -383,200,000USD | — | — | — | — | — | — | — |
| Stockholders’ equity (Note 8) | 8,328,400,000USD | — | — | — | — | — | — | — |
| Additional paid in capital | 1,998,500,000USD | — | — | — | — | — | — | — |
| Common stock, $0.10 par value, 480.0 shares authorized, 217.9 issued and 190.1 outstanding at July 31, 2026, and 217.6 issued and 195.9 outstanding at October 31, 2025 | 21,800,000USD | — | — | — | — | — | — | — |
| Prepaid expense and other current assets | 426,400,000USD | — | — | — | — | — | — | — |
| Treasury stock at cost: 27.8 shares at July 31, 2026, and 21.7 shares at October 31, 2025 | -1,437,900,000USD | — | — | — | — | — | — | — |
| Other liabilities | 257,000,000USD | — | — | — | — | — | — | — |
| Goodwill | 3,876,300,000USD | — | — | — | — | — | — | — |
| Total current assets | 2,281,500,000USD | — | — | — | — | — | — | — |
| Cash and cash equivalents | 154,700,000USD | — | — | — | — | — | — | — |
| Long term tax payable | 2,400,000USD | — | — | — | — | — | — | — |
| Total Assets | — | 12,482,300,000USD | 12,424,200,000USD | 12,394,800,000USD | 12,376,700,000USD | 12,413,600,000USD | 12,222,200,000USD | 12,315,200,000USD |
| Intangible Assets | — | 1,494,300,000USD | 1,541,600,000USD | 1,586,300,000USD | 1,635,900,000USD | 1,694,000,000USD | 1,739,400,000USD | 1,791,000,000USD |
| Other Current Assets | — | 455,400,000USD | 325,400,000USD | 320,800,000USD | 339,600,000USD | 348,300,000USD | 326,800,000USD | 324,200,000USD |
| Total Liab | — | 4,243,200,000USD | 4,060,200,000USD | 4,155,700,000USD | 4,023,700,000USD | 4,125,500,000USD | 4,094,700,000USD | 4,231,600,000USD |
| Total Stockholder Equity | — | 8,239,100,000USD | 8,364,000,000USD | 8,238,900,000USD | 8,353,000,000USD | 8,287,900,000USD | 8,127,300,000USD | 8,083,400,000USD |
| Other Current Liab | — | 844,600,000USD | 619,300,000USD | 598,200,000USD | 579,800,000USD | 580,900,000USD | 623,100,000USD | 599,100,000USD |
| Common Stock | — | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,700,000USD | 21,700,000USD |
| Capital Stock | — | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,800,000USD | 21,700,000USD | 21,700,000USD |
| Retained Earnings | — | 7,696,200,000USD | 7,774,100,000USD | 7,643,300,000USD | 7,558,700,000USD | 7,460,400,000USD | 7,372,700,000USD | 7,268,400,000USD |
| Good Will | — | 3,888,500,000USD | 3,905,400,000USD | 3,853,400,000USD | 3,861,800,000USD | 3,864,700,000USD | 3,792,100,000USD | 3,838,400,000USD |
| Cash | — | 138,800,000USD | 124,900,000USD | 110,600,000USD | 124,900,000USD | 116,200,000USD | 100,900,000USD | 107,600,000USD |
| Cash And Short Term Investments | — | 138,800,000USD | 124,900,000USD | 110,600,000USD | 124,900,000USD | 116,200,000USD | 100,900,000USD | 107,600,000USD |
| Total Current Assets | — | 2,299,800,000USD | 2,133,800,000USD | 2,106,400,000USD | 2,137,800,000USD | 2,125,700,000USD | 1,987,000,000USD | 1,951,500,000USD |
| Total Current Liabilities | — | 1,804,700,000USD | 1,595,700,000USD | 1,112,800,000USD | 1,010,100,000USD | 1,012,500,000USD | 999,600,000USD | 1,022,800,000USD |
| Current Deferred Revenue | — | 127,900,000USD | 129,900,000USD | 127,900,000USD | 126,600,000USD | 127,600,000USD | 126,300,000USD | 129,900,000USD |
| Net Debt | — | 2,321,400,000USD | 2,374,800,000USD | 2,673,000,000USD | 2,353,400,000USD | 2,469,200,000USD | 2,439,000,000USD | 2,476,100,000USD |
| Short Term Debt | — | 598,900,000USD | 620,700,000USD | 86,300,000USD | 47,800,000USD | 59,800,000USD | 48,700,000USD | 33,300,000USD |
| Short Long Term Debt | — | 598,200,000USD | 620,100,000USD | 47,100,000USD | 46,000,000USD | 58,800,000USD | 47,700,000USD | 32,200,000USD |
| Short Long Term Debt Total | — | 2,460,200,000USD | 2,499,700,000USD | 2,783,600,000USD | 2,478,300,000USD | 2,585,400,000USD | 2,539,900,000USD | 2,583,700,000USD |
| Long Term Debt | — | 1,859,500,000USD | 1,877,300,000USD | 2,455,700,000USD | 2,429,500,000USD | 2,523,600,000USD | 2,489,100,000USD | 2,548,000,000USD |
| Net Receivables | — | 809,200,000USD | 807,100,000USD | 829,000,000USD | 792,300,000USD | 780,900,000USD | 716,400,000USD | 717,000,000USD |
| Inventory | — | 896,400,000USD | 876,400,000USD | 846,000,000USD | 881,000,000USD | 880,300,000USD | 842,900,000USD | 802,700,000USD |
| Accounts Payable | — | 233,300,000USD | 225,800,000USD | 300,400,000USD | 255,900,000USD | 244,200,000USD | 201,500,000USD | 260,500,000USD |
| Property Plant Equipment Net | — | 2,132,200,000USD | 2,116,699,999USD | 2,082,000,000USD | 1,988,700,000USD | 1,928,500,000USD | 1,864,700,000USD | 1,863,400,000USD |
| Accumulated Other Comprehensive Income | — | -363,200,000USD | -334,000,000USD | -406,500,000USD | -392,099,999USD | -392,300,000USD | -490,400,000USD | -421,700,000USD |
| Common Stock Shares Outstanding | — | 195,000,000shares | 196,700,000shares | 198,100,000shares | 200,600,000shares | 200,700,000shares | 201,200,000shares | 201,100,000shares |
| Non Current Assets Total | — | 10,182,500,000USD | 10,290,400,000USD | 10,288,400,000USD | 10,238,900,000USD | 10,287,900,000USD | 10,235,200,000USD | 10,363,700,000USD |
| Non Current Liabilities Total | — | 2,438,500,000USD | 2,464,500,000USD | 3,042,899,999USD | 3,013,600,000USD | 3,113,000,000USD | 3,095,100,000USD | 3,208,800,000USD |
| Non Current Liabilities Other | — | 266,400,000USD | 277,200,000USD | 282,800,000USD | 263,200,000USD | 274,200,000USD | 261,000,000USD | 311,600,000USD |
| Non Currrent Assets Other | — | 672,800,000USD | 688,400,000USD | 689,200,000USD | 653,300,000USD | 659,000,000USD | 663,700,000USD | 660,600,000USD |
| Net Working Capital | — | 495,100,000USD | 538,100,000USD | 993,600,000USD | 1,127,700,000USD | 1,113,200,000USD | 987,400,000USD | 928,700,000USD |
| Unclassified Non Current Assets | — | 1,994,700,000USD | 2,038,300,001USD | 2,077,500,000USD | 2,099,200,000USD | 2,141,700,000USD | 2,175,300,000USD | 2,210,300,000USD |
| Unclassified Current Liabilities | — | -598,200,000USD | -620,100,000USD | -47,100,000USD | -46,000,000USD | -58,800,000USD | -47,700,000USD | -32,200,000USD |
| Unclassified Non Current Liabilities | — | 312,600,000USD | 310,000,000USD | 304,399,999USD | 320,900,000USD | 315,200,000USD | 345,000,000USD | 349,200,000USD |
| Unclassified Equity | — | 862,500,000USD | 880,300,000USD | 958,500,000USD | 1,142,799,999USD | 1,176,200,000USD | 1,201,600,000USD | 1,193,300,000USD |
| Property Plant Equipment Gross | — | — | — | 3,908,400,000USD | — | — | — | 3,559,900,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD | FY 20192019-10-31 · USD | FY 20182018-10-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 12,394,800,000USD | 12,315,200,000USD | 11,658,900,000USD | 11,492,300,000USD | 9,606,200,000USD | 6,737,500,000USD | 6,274,500,000USD | 6,112,800,000USD |
| Intangible Assets | 1,586,300,000USD | 1,791,000,000USD | 1,710,300,000USD | 1,885,100,000USD | 1,271,500,000USD | 1,289,000,000USD | 1,405,300,000USD | 1,521,300,000USD |
| Other Current Assets | 320,800,000USD | 324,200,000USD | 238,800,000USD | 208,900,000USD | 268,500,000USD | 152,500,000USD | 132,200,000USD | 169,700,000USD |
| Total Liab | 4,155,700,000USD | 4,231,600,000USD | 4,107,900,000USD | 4,317,600,000USD | 2,664,200,000USD | 2,912,700,000USD | 2,646,000,000USD | 2,805,000,000USD |
| Total Stockholder Equity | 8,238,900,000USD | 8,083,400,000USD | 7,550,800,000USD | 7,174,500,000USD | 6,941,800,000USD | 3,824,600,000USD | 3,628,400,000USD | 3,307,600,000USD |
| Other Current Liab | 598,200,000USD | 599,100,000USD | 538,100,000USD | 525,200,000USD | 468,300,000USD | 385,800,000USD | 396,800,000USD | 353,000,000USD |
| Common Stock | 21,800,000USD | 21,700,000USD | 21,600,000USD | 5,400,000USD | 5,400,000USD | 5,300,000USD | 5,300,000USD | 5,300,000USD |
| Capital Stock | 21,800,000USD | 21,700,000USD | 5,400,000USD | 5,400,000USD | 5,400,000USD | 5,300,000USD | 5,300,000USD | 5,300,000USD |
| Retained Earnings | 7,643,300,000USD | 7,268,400,000USD | 6,876,100,000USD | 6,584,900,000USD | 6,202,100,000USD | 3,261,800,000USD | 3,026,400,000USD | 2,576,000,000USD |
| Good Will | 3,853,400,000USD | 3,838,400,000USD | 3,624,500,000USD | 3,609,700,000USD | 2,574,000,000USD | 2,447,300,000USD | 2,428,900,000USD | 2,392,100,000USD |
| Cash | 110,600,000USD | 107,600,000USD | 120,800,000USD | 138,200,000USD | 95,900,000USD | 115,900,000USD | 89,000,000USD | 77,700,000USD |
| Cash And Short Term Investments | 110,600,000USD | 107,600,000USD | 120,800,000USD | 138,200,000USD | 95,900,000USD | 115,900,000USD | 89,000,000USD | 77,700,000USD |
| Total Current Assets | 2,106,400,000USD | 1,951,500,000USD | 1,704,900,000USD | 1,533,600,000USD | 1,465,300,000USD | 1,274,200,000USD | 1,163,400,000USD | 1,090,900,000USD |
| Total Current Liabilities | 1,112,800,000USD | 1,022,800,000USD | 969,000,000USD | 1,280,200,000USD | 732,100,000USD | 1,004,400,000USD | 1,110,600,000USD | 536,500,000USD |
| Current Deferred Revenue | 127,900,000USD | 129,900,000USD | 123,600,000USD | 93,600,000USD | 19,000,000USD | -176,000,000USD | -150,100,000USD | -146,400,000USD |
| Net Debt | 2,673,000,000USD | 2,476,100,000USD | 2,448,400,000USD | 2,625,200,000USD | 1,385,100,000USD | 1,947,400,000USD | 1,737,300,000USD | 1,945,100,000USD |
| Short Term Debt | 86,300,000USD | 33,300,000USD | 45,400,000USD | 412,600,000USD | 83,400,000USD | 442,600,000USD | 563,700,000USD | 37,100,000USD |
| Short Long Term Debt | 47,100,000USD | 32,200,000USD | 45,400,000USD | 412,600,000USD | 82,900,000USD | 409,300,000USD | 563,700,000USD | 37,100,000USD |
| Short Long Term Debt Total | 2,783,600,000USD | 2,583,700,000USD | 2,569,200,000USD | 2,763,400,000USD | 1,481,000,000USD | 2,063,300,000USD | 1,826,300,000USD | 2,022,800,000USD |
| Long Term Debt | 2,455,700,000USD | 2,548,000,000USD | 2,523,800,000USD | 2,350,800,000USD | 1,396,100,000USD | 1,383,900,000USD | 1,262,600,000USD | 1,985,700,000USD |
| Net Receivables | 829,000,000USD | 717,000,000USD | 609,700,000USD | 557,800,000USD | 515,300,000USD | 435,400,000USD | 435,300,000USD | 374,700,000USD |
| Inventory | 846,000,000USD | 802,700,000USD | 735,600,000USD | 628,700,000USD | 585,600,000USD | 570,400,000USD | 506,900,000USD | 468,800,000USD |
| Accounts Payable | 300,400,000USD | 260,500,000USD | 261,900,000USD | 248,800,000USD | 161,400,000USD | 176,000,000USD | 150,100,000USD | 146,400,000USD |
| Property Plant Equipment Net | 2,082,000,000USD | 1,863,400,000USD | 1,632,600,000USD | 1,432,900,000USD | 1,347,600,000USD | 1,542,100,000USD | 1,132,100,000USD | 976,000,000USD |
| Property Plant Equipment Gross | 3,908,400,000USD | 3,559,900,000USD | 3,185,900,000USD | 1,432,900,000USD | 2,655,700,000USD | 1,542,100,000USD | 1,132,100,000USD | 976,000,000USD |
| Accumulated Other Comprehensive Income | -406,500,000USD | -421,700,000USD | -453,800,000USD | -466,800,000USD | -341,300,000USD | -472,000,000USD | -447,100,000USD | -430,700,000USD |
| Common Stock Shares Outstanding | 200,000,000shares | 200,400,000shares | 199,200,000shares | 198,800,000shares | 199,400,000shares | 198,200,000shares | 200,200,000shares | 198,800,000shares |
| Non Current Assets Total | 10,288,400,000USD | 10,363,700,000USD | 9,954,000,000USD | 9,958,700,000USD | 8,140,900,000USD | 5,463,300,000USD | 5,111,100,000USD | 5,021,900,000USD |
| Non Current Liabilities Total | 3,042,899,999USD | 3,208,800,000USD | 3,138,900,000USD | 3,037,400,000USD | 1,932,100,000USD | 1,908,300,000USD | 1,535,300,000USD | 2,268,500,000USD |
| Non Current Liabilities Other | 282,800,000USD | 311,600,000USD | 239,200,000USD | 311,500,000USD | 371,300,000USD | 398,800,000USD | 124,800,000USD | 141,500,000USD |
| Non Currrent Assets Other | 689,200,000USD | 660,600,000USD | 637,100,000USD | 587,900,000USD | 401,200,000USD | 104,800,000USD | 66,800,000USD | 74,100,000USD |
| Net Working Capital | 993,600,000USD | 928,700,000USD | 735,900,000USD | 253,400,000USD | 733,200,000USD | 269,800,000USD | 52,800,000USD | 554,400,000USD |
| Unclassified Non Current Assets | 2,077,500,000USD | 2,210,300,000USD | -637,100,000USD | -587,900,000USD | -144,200,000USD | -104,800,000USD | -66,800,000USD | -74,100,000USD |
| Unclassified Current Liabilities | -47,100,000USD | -32,200,000USD | -45,400,000USD | -412,600,000USD | -82,900,000USD | -409,300,000USD | -563,700,000USD | -37,100,000USD |
| Unclassified Non Current Liabilities | 304,399,999USD | 349,200,000USD | -239,200,000USD | -461,400,000USD | -163,700,000USD | -171,300,000USD | -152,800,000USD | -141,500,000USD |
| Unclassified Equity | 958,500,000USD | 1,193,300,000USD | 1,101,500,000USD | 1,045,600,000USD | 1,709,800,000USD | 1,641,500,000USD | 1,609,700,000USD | — |
| Other Liab | — | — | 615,100,000USD | 686,600,000USD | 304,300,000USD | 271,100,000USD | 272,700,000USD | 282,800,000USD |
| Other Assets | — | — | 2,986,600,000USD | 3,031,000,000USD | 2,690,800,000USD | 184,900,000USD | 144,800,000USD | 132,500,000USD |
| Short Term Investments | — | — | 100,000USD | — | — | — | — | 2,500,000USD |
| Net Tangible Assets | — | — | 2,216,000,000USD | 1,679,900,000USD | 3,096,500,000USD | 88,300,000USD | -205,800,000USD | -605,800,000USD |
| Deferred Long Term Liab | — | — | — | 149,900,000USD | 24,100,000USD | 25,800,000USD | 28,000,000USD | 0USD |
| Cash And Equivalents | — | — | — | 138,200,000USD | 95,900,000USD | 115,900,000USD | 89,000,000USD | 77,700,000USD |
| Accumulated Depreciation | — | — | — | — | -1,308,100,000USD | -1,192,900,000USD | -1,061,800,000USD | -954,300,000USD |
| Treasury Stock | — | — | — | — | -639,600,000USD | -617,300,000USD | -571,200,000USD | -415,100,000USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 1,572,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20262026-07-31 · USD |
|---|---|
| Net payments related to share based compensation awards | -29,200,000USD |
| Acquisition installment payment | -44,500,000USD |
| Net income | 485,700,000USD |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,800,000USD |
| Net cash provided by operating activities | 785,400,000USD |
| Net increase in cash, cash equivalents, and restricted cash | 44,300,000USD |
| Net cash used in financing activities | -476,600,000USD |
| Acquisitions of businesses and assets, net of cash acquired, and other | -5,400,000USD |
| Deferred income taxes | -187,800,000USD |
| Repurchase of common stock | -447,200,000USD |
| Net changes in operating capital | -111,000,000USD |
| Net cash used in investing activities | -262,700,000USD |
| Repayments of long term debt | -2,839,700,000USD |
| Settlement of contingent consideration | -500,000USD |
| Issuance of common stock for employee stock purchase plan | 7,400,000USD |
| Other non cash items | -91,400,000USD |
| Purchases of property, plant and equipment | -257,300,000USD |
| Depreciation and amortization | 285,600,000USD |
| Net proceeds from short term debt | 30,800,000USD |
| Proceeds from long term debt, net of issuance costs | 2,847,100,000USD |
| Source | DisclosureVerified |
Cash flow Quarterly
| Metric | Q2 20262026-04-30 · USD | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD | Q3 20242024-07-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -77,900,000USD | 130,800,000USD | 84,600,000USD | 98,300,000USD | 87,700,000USD | 104,300,000USD | 117,500,000USD | 104,700,000USD |
| Depreciation | 95,400,000USD | 95,500,000USD | 98,400,000USD | 95,400,000USD | 92,600,000USD | 91,000,000USD | 91,000,000USD | 89,000,000USD |
| Other Non Cash Items | 30,200,000USD | 27,099,999USD | 77,000,000USD | 42,299,999USD | 37,800,000USD | 36,300,000USD | -28,099,999USD | 27,400,000USD |
| Change In Working Capital | 91,600,000USD | -36,100,000USD | -25,100,000USD | -18,500,000USD | -165,600,000USD | -75,600,000USD | -31,200,000USD | -49,800,000USD |
| Total Cash From Operating Activities | 182,800,000USD | 260,899,999USD | 247,900,000USD | 261,399,999USD | 96,200,000USD | 190,600,000USD | 268,100,000USD | 207,500,000USD |
| Capital Expenditures | -86,400,000USD | -102,199,999USD | -98,000,000USD | -96,899,999USD | -78,100,000USD | -89,400,000USD | -140,000,000USD | -89,000,000USD |
| Free Cash Flow | 96,400,000USD | 158,700,000USD | 149,900,000USD | 164,500,000USD | 18,100,000USD | 101,200,000USD | 128,100,000USD | 118,500,000USD |
| Total Cashflows From Investing Activities | -90,000,000USD | -102,900,000USD | -98,800,000USD | -98,100,000USD | -79,200,000USD | -96,800,000USD | -241,600,000USD | -124,100,000USD |
| Net Borrowings | -38,300,000USD | -6,800,000USD | 28,000,000USD | -105,900,000USD | 41,200,000USD | -43,200,000USD | -49,600,000USD | -89,500,000USD |
| Total Cash From Financing Activities | -75,800,000USD | -147,900,000USD | -164,400,000USD | -156,300,000USD | -8,600,000USD | -96,600,000USD | -28,400,000USD | -87,600,000USD |
| Sale Purchase Of Stock | -15,500,000USD | -92,500,000USD | -196,800,000USD | -52,700,000USD | -40,600,000USD | 0USD | — | 0USD |
| Change In Cash | 14,000,000USD | 14,300,000USD | -14,300,000USD | 8,700,000USD | 15,200,000USD | -6,700,000USD | -2,100,000USD | -2,800,000USD |
| Begin Period Cash Flow | 125,000,000USD | 110,600,000USD | 124,900,000USD | 116,200,000USD | 101,000,000USD | 107,700,000USD | 109,800,000USD | 112,600,000USD |
| End Period Cash Flow | 139,000,000USD | 124,900,000USD | 110,600,000USD | 124,900,000USD | 116,200,000USD | 101,000,000USD | 107,700,000USD | 109,800,000USD |
| Other Cashflows From Investing Activities | -188,800,000USD | -700,000USD | 9,700,000USD | -1,200,000USD | -1,100,000USD | -7,400,000USD | 241,800,000USD | -35,100,000USD |
| Other Cashflows From Financing Activities | -22,000,000USD | -45,800,000USD | -5,100,000USD | 2,300,000USD | -11,200,000USD | -55,600,000USD | -36,800,000USD | -300,000USD |
| Unclassified Operating Cash Flow | 43,500,000USD | 43,600,000USD | 13,000,000USD | 43,900,000USD | 43,700,000USD | 34,600,000USD | 118,899,999USD | 18,600,000USD |
| Unclassified Investing Cash Flow | 185,200,000USD | — | -10,500,000USD | 98,099,999USD | 79,200,000USD | 96,800,000USD | -101,800,000USD | 124,100,000USD |
| Unclassified Financing Cash Flow | — | -2,800,000USD | 9,500,000USD | — | 2,000,000USD | 2,200,000USD | 58,000,000USD | 2,200,000USD |
| Investments | — | — | — | -98,100,000USD | -79,200,000USD | -96,800,000USD | -241,600,000USD | -124,100,000USD |
| Dividends Paid | — | — | — | — | — | — | 0USD | 0USD |
| Stock Based Compensation | — | — | — | — | — | — | — | 17,600,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD | FY 20192019-10-31 · USD | FY 20182018-10-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 374,900,000USD | 392,300,000USD | 294,200,000USD | 385,800,000USD | 2,944,700,000USD | 238,400,000USD | 466,700,000USD | 139,900,000USD |
| Depreciation | 423,000,000USD | 413,800,000USD | 367,700,000USD | 346,100,000USD | 309,300,000USD | 287,100,000USD | 280,800,000USD | 275,100,000USD |
| Stock Based Compensation | 70,500,000USD | 75,100,000USD | 62,100,000USD | 54,200,000USD | 43,800,000USD | 37,600,000USD | 35,100,000USD | 43,200,000USD |
| Other Non Cash Items | 147,800,000USD | 118,000,000USD | 57,600,000USD | 26,400,000USD | 92,900,000USD | 50,200,000USD | -13,400,000USD | 88,200,000USD |
| Change To Account Receivables | -120,300,000USD | -117,100,000USD | -60,200,000USD | -33,800,000USD | -75,500,000USD | 8,500,000USD | -55,600,000USD | -59,500,000USD |
| Change To Inventory | -46,000,000USD | -59,300,000USD | -105,400,000USD | -40,400,000USD | -9,200,000USD | -62,300,000USD | -37,300,000USD | -5,000,000USD |
| Change In Working Capital | -284,800,000USD | -333,700,000USD | -218,800,000USD | -174,000,000USD | -149,900,000USD | -125,800,000USD | -40,100,000USD | 119,600,000USD |
| Total Cash From Operating Activities | 796,100,000USD | 709,300,000USD | 607,500,000USD | 692,400,000USD | 738,600,000USD | 486,600,000USD | 713,200,000USD | 668,900,000USD |
| Capital Expenditures | -362,400,000USD | -421,200,000USD | -392,500,000USD | -242,000,000USD | -214,400,000USD | -310,400,000USD | -292,100,000USD | -193,600,000USD |
| Free Cash Flow | 433,700,000USD | 288,100,000USD | 215,000,000USD | 450,400,000USD | 524,200,000USD | 176,200,000USD | 421,100,000USD | 475,300,000USD |
| Total Cashflows From Investing Activities | -372,900,000USD | -764,600,000USD | -449,000,000USD | -1,831,200,000USD | -450,300,000USD | -364,500,000USD | -351,300,000USD | -1,517,500,000USD |
| Net Borrowings | -79,900,000USD | 5,600,000USD | -180,800,000USD | 1,278,800,000USD | -309,900,000USD | -42,700,000USD | -200,100,000USD | 849,600,000USD |
| Total Cash From Financing Activities | -425,900,000USD | 39,200,000USD | -173,900,000USD | 1,193,700,000USD | -311,400,000USD | -95,500,000USD | -351,400,000USD | 844,400,000USD |
| Dividends Paid | 0USD | 0USD | -3,000,000USD | -3,000,000USD | -3,000,000USD | -3,000,000USD | -3,000,000USD | -2,900,000USD |
| Sale Purchase Of Stock | -290,100,000USD | 8,300,000USD | -23,000,000USD | -78,500,000USD | -24,800,000USD | -47,800,000USD | -156,100,000USD | 22,300,000USD |
| Change In Cash | 2,900,000USD | -13,200,000USD | -17,700,000USD | 42,000,000USD | -20,200,000USD | 27,300,000USD | 11,800,000USD | -11,100,000USD |
| Begin Period Cash Flow | 107,700,000USD | 120,900,000USD | 138,600,000USD | 96,600,000USD | 116,800,000USD | 89,500,000USD | 77,700,000USD | 88,800,000USD |
| End Period Cash Flow | 110,600,000USD | 107,700,000USD | 120,900,000USD | 138,600,000USD | 96,600,000USD | 116,800,000USD | 89,500,000USD | 77,700,000USD |
| Other Cashflows From Financing Activities | -71,900,000USD | -30,299,999USD | 1,783,000,000USD | 1,836,700,000USD | -100,000USD | -3,500,000USD | 7,400,000USD | 1,600,000USD |
| Unclassified Operating Cash Flow | 64,700,000USD | 43,800,000USD | 44,700,000USD | 53,900,000USD | -2,502,200,000USD | — | -15,900,000USD | — |
| Unclassified Investing Cash Flow | -10,500,000USD | 421,200,000USD | 392,500,000USD | — | 450,300,000USD | 364,500,000USD | 351,300,000USD | 1,517,500,000USD |
| Unclassified Financing Cash Flow | 16,000,000USD | 55,599,999USD | -1,750,100,000USD | -1,840,300,000USD | 26,400,000USD | 1,500,000USD | — | -26,200,000USD |
| Investments | — | -764,600,000USD | -449,000,000USD | 52,100,000USD | -450,300,000USD | -364,500,000USD | -351,300,000USD | -1,517,500,000USD |
| Change To Liabilities | — | — | 5,500,000USD | 20,700,000USD | 31,400,000USD | -10,900,000USD | 13,000,000USD | 2,900,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 54,900,000USD | -23,100,000USD | 26,600,000USD | 10,500,000USD | -8,600,000USD |
| Other Cashflows From Investing Activities | — | — | — | -1,641,300,000USD | -235,900,000USD | -54,100,000USD | -59,200,000USD | -1,323,900,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -4,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-04-30 | Geography | Europe | 341,600,000 | USD | 0001628280-26-041305 |
| Q2 2026Quarterly · 2026-04-30 | Geography | Rest Of World Excluding United States And Europe | 192,100,000 | USD | 0001628280-26-041305 |
| Q2 2026Quarterly · 2026-04-30 | Geography | United States | 547,800,000 | USD | 0001628280-26-041305 |
| Q1 2026Quarterly · 2026-01-31 | Geography | Europe | 326,400,000 | USD | 0001628280-26-015620 |
| Q1 2026Quarterly · 2026-01-31 | Geography | Rest Of World Excluding United States And Europe | 183,800,000 | USD | 0001628280-26-015620 |
| Q1 2026Quarterly · 2026-01-31 | Geography | United States | 513,900,000 | USD | 0001628280-26-015620 |
| FY 2025Yearly · 2025-10-31 | Geography | Europe | 1,253,200,000 | USD | 0001628280-25-055615 |
| FY 2025Yearly · 2025-10-31 | Geography | Rest of World | 785,200,000 | USD | 0001628280-25-055615 |
| FY 2025Yearly · 2025-10-31 | Geography | United States | 2,054,000,000 | USD | 0001628280-25-055615 |
| Q3 2025Quarterly · 2025-07-31 | Geography | Europe | 343,100,000 | USD | 0000711404-25-000051 |
| Q3 2025Quarterly · 2025-07-31 | Geography | Rest Of World Excluding United States And Europe | 201,000,000 | USD | 0000711404-25-000051 |
| Q3 2025Quarterly · 2025-07-31 | Geography | United States | 516,200,000 | USD | 0000711404-25-000051 |
| Q3 2025Quarterly · 2025-07-31 | Segment | Coopersurgical | 341,900,000 | USD | 0000711404-25-000051 |
| Q3 2025Quarterly · 2025-07-31 | Segment | Coopervision | 718,400,000 | USD | 0000711404-25-000051 |
| Q2 2025Quarterly · 2025-04-30 | Geography | Europe | 291,900,000 | USD | 0001628280-26-041305 |
| Q2 2025Quarterly · 2025-04-30 | Geography | Rest Of World Excluding United States And Europe | 195,200,000 | USD | 0001628280-26-041305 |
| Q2 2025Quarterly · 2025-04-30 | Geography | United States | 515,200,000 | USD | 0001628280-26-041305 |
| Q2 2025Quarterly · 2025-04-30 | Segment | Coopersurgical | 332,700,000 | USD | 0000711404-25-000040 |
| Q2 2025Quarterly · 2025-04-30 | Segment | Coopervision | 669,600,000 | USD | 0000711404-25-000040 |
| Q1 2025Quarterly · 2025-01-31 | Geography | Europe | 287,500,000 | USD | 0001628280-26-015620 |
| Q1 2025Quarterly · 2025-01-31 | Geography | Rest Of World Excluding United States And Europe | 180,800,000 | USD | 0001628280-26-015620 |
| Q1 2025Quarterly · 2025-01-31 | Geography | United States | 496,400,000 | USD | 0001628280-26-015620 |
| Q1 2025Quarterly · 2025-01-31 | Segment | Coopersurgical | 318,600,000 | USD | 0000711404-25-000015 |
| Q1 2025Quarterly · 2025-01-31 | Segment | Coopervision | 646,100,000 | USD | 0000711404-25-000015 |
| FY 2024Yearly · 2024-10-31 | Geography | Europe | 1,155,900,000 | USD | 0001628280-25-055615 |
| FY 2024Yearly · 2024-10-31 | Geography | Rest of World | 773,600,000 | USD | 0001628280-25-055615 |
| FY 2024Yearly · 2024-10-31 | Geography | United States | 1,965,900,000 | USD | 0001628280-25-055615 |
| Q3 2024Quarterly · 2024-07-31 | Geography | Europe | 297,000,000 | USD | 0000711404-25-000051 |
| Q3 2024Quarterly · 2024-07-31 | Geography | Rest Of World Excluding United States And Europe | 194,600,000 | USD | 0000711404-25-000051 |
| Q3 2024Quarterly · 2024-07-31 | Geography | United States | 511,200,000 | USD | 0000711404-25-000051 |
| Q3 2024Quarterly · 2024-07-31 | Segment | Coopersurgical | 327,200,000 | USD | 0000711404-25-000051 |
| Q3 2024Quarterly · 2024-07-31 | Segment | Coopervision | 675,600,000 | USD | 0000711404-25-000051 |
| Q2 2024Quarterly · 2024-04-30 | Geography | Europe | 276,700,000 | USD | 0000711404-25-000040 |
| Q2 2024Quarterly · 2024-04-30 | Geography | Rest Of World Excluding United States And Europe | 186,900,000 | USD | 0000711404-25-000040 |
| Q2 2024Quarterly · 2024-04-30 | Geography | United States | 479,000,000 | USD | 0000711404-25-000040 |
| Q2 2024Quarterly · 2024-04-30 | Segment | Coopersurgical | 306,700,000 | USD | 0000711404-25-000040 |
| Q2 2024Quarterly · 2024-04-30 | Segment | Coopervision | 635,900,000 | USD | 0000711404-25-000040 |
| Q1 2024Quarterly · 2024-01-31 | Geography | Europe | 276,600,000 | USD | 0000711404-25-000015 |
| Q1 2024Quarterly · 2024-01-31 | Geography | Rest Of World Excluding United States And Europe | 184,600,000 | USD | 0000711404-25-000015 |
| Q1 2024Quarterly · 2024-01-31 | Geography | United States | 470,400,000 | USD | 0000711404-25-000015 |
| Q1 2024Quarterly · 2024-01-31 | Segment | Coopersurgical | 310,100,000 | USD | 0000711404-25-000015 |
| Q1 2024Quarterly · 2024-01-31 | Segment | Coopervision | 621,500,000 | USD | 0000711404-25-000015 |
| FY 2023Yearly · 2023-10-31 | Geography | Europe | 1,041,200,000 | USD | 0001628280-25-055615 |
| FY 2023Yearly · 2023-10-31 | Geography | Rest of World | 739,800,000 | USD | 0001628280-25-055615 |
| FY 2023Yearly · 2023-10-31 | Geography | United States | 1,812,200,000 | USD | 0001628280-25-055615 |
| FY 2023Yearly · 2023-10-31 | Segment | Cooper Surgical | 1,169,500,000 | USD | 0000711404-23-000072 |
| FY 2023Yearly · 2023-10-31 | Segment | Cooper Vision | 2,423,700,000 | USD | 0000711404-23-000072 |
| Q3 2023Quarterly · 2023-07-31 | Segment | Coopersurgical | 300,000,000 | USD | 0000711404-24-000062 |
| Q3 2023Quarterly · 2023-07-31 | Segment | Coopervision | 630,200,000 | USD | 0000711404-24-000062 |
| Q2 2023Quarterly · 2023-04-30 | Segment | Coopersurgical | 288,100,000 | USD | 0000711404-24-000043 |
| Q2 2023Quarterly · 2023-04-30 | Segment | Coopervision | 589,300,000 | USD | 0000711404-24-000043 |
| FY 2022Yearly · 2022-10-31 | Geography | Europe | 987,200,000 | USD | 0000711404-24-000074 |
| FY 2022Yearly · 2022-10-31 | Geography | Rest of World | 682,700,000 | USD | 0000711404-24-000074 |
| FY 2022Yearly · 2022-10-31 | Geography | United States | 1,638,500,000 | USD | 0000711404-24-000074 |
| FY 2022Yearly · 2022-10-31 | Segment | Cooper Surgical | 1,065,100,000 | USD | 0000711404-23-000072 |
| FY 2022Yearly · 2022-10-31 | Segment | Cooper Vision | 2,243,300,000 | USD | 0000711404-23-000072 |
| FY 2021Yearly · 2021-10-31 | Geography | Europe | 957,900,000 | USD | 0000711404-23-000072 |
| FY 2021Yearly · 2021-10-31 | Geography | Rest of World | 625,400,000 | USD | 0000711404-23-000072 |
| FY 2021Yearly · 2021-10-31 | Geography | United States | 1,339,200,000 | USD | 0000711404-23-000072 |
| FY 2021Yearly · 2021-10-31 | Segment | Cooper Surgical | 770,500,000 | USD | 0000711404-23-000072 |
| FY 2021Yearly · 2021-10-31 | Segment | Cooper Vision | 2,152,000,000 | USD | 0000711404-23-000072 |
| FY 2020Yearly · 2020-10-31 | Geography | Europe | 789,800,000 | USD | 0000711404-22-000053 |
| FY 2020Yearly · 2020-10-31 | Geography | Rest of World | 537,500,000 | USD | 0000711404-22-000053 |
| FY 2020Yearly · 2020-10-31 | Geography | United States | 1,103,600,000 | USD | 0000711404-22-000053 |
| FY 2020Yearly · 2020-10-31 | Segment | Coopersurgical | 587,900,000 | USD | 0000711404-22-000053 |
| FY 2020Yearly · 2020-10-31 | Segment | Coopervision | 1,843,000,000 | USD | 0000711404-22-000053 |
| FY 2019Yearly · 2019-10-31 | Geography | Europe | 854,800,000 | USD | 0000711404-21-000038 |
| FY 2019Yearly · 2019-10-31 | Geography | Rest of World | 586,800,000 | USD | 0000711404-21-000038 |
| FY 2019Yearly · 2019-10-31 | Geography | United States | 1,211,800,000 | USD | 0000711404-21-000038 |
| FY 2019Yearly · 2019-10-31 | Segment | Coopersurgical | 680,500,000 | USD | 0000711404-21-000038 |
| FY 2019Yearly · 2019-10-31 | Segment | Coopervision | 1,972,900,000 | USD | 0000711404-21-000038 |
| FY 2018Yearly · 2018-10-31 | Geography | Europe | 846,500,000 | USD | 0000711404-20-000042 |
| FY 2018Yearly · 2018-10-31 | Geography | Rest of World | 524,100,000 | USD | 0000711404-20-000042 |
| FY 2018Yearly · 2018-10-31 | Geography | United States | 1,162,200,000 | USD | 0000711404-20-000042 |
| FY 2018Yearly · 2018-10-31 | Segment | Coopersurgical | 650,800,000 | USD | 0000711404-18-000047 |
| FY 2018Yearly · 2018-10-31 | Segment | Coopervision | 1,882,000,000 | USD | 0000711404-18-000047 |
| FY 2018Yearly · 2018-10-31 | Segment | Corporate | 0 | USD | 0000711404-18-000047 |
| FY 2017Yearly · 2017-10-31 | Segment | Coopersurgical | 464,900,000 | USD | 0000711404-18-000047 |
| FY 2017Yearly · 2017-10-31 | Segment | Coopervision | 1,674,100,000 | USD | 0000711404-18-000047 |
| FY 2017Yearly · 2017-10-31 | Segment | Corporate | 0 | USD | 0000711404-18-000047 |
| FY 2016Yearly · 2016-10-31 | Segment | Coopersurgical | 389,600,000 | USD | 0000711404-18-000047 |
| FY 2016Yearly · 2016-10-31 | Segment | Coopervision | 1,577,200,000 | USD | 0000711404-18-000047 |
| FY 2016Yearly · 2016-10-31 | Segment | Corporate | 0 | USD | 0000711404-18-000047 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.